AR073089A1 - DERIVADOS DE (POLI)AMINOALQUILAMINOALQUILAMIDAS, ALQUIL-UREA O ALQUILSULFONAMIDA DE EPIPODOFILOTOXINA, UN PROCESO PARA PREPARARLOS, SU APLICACIoN EN TERAPIA COMO AGENTES ANTICANCER Y COMPOSICION FARMACEUTICA QUE LOS CONTIENEN. - Google Patents
DERIVADOS DE (POLI)AMINOALQUILAMINOALQUILAMIDAS, ALQUIL-UREA O ALQUILSULFONAMIDA DE EPIPODOFILOTOXINA, UN PROCESO PARA PREPARARLOS, SU APLICACIoN EN TERAPIA COMO AGENTES ANTICANCER Y COMPOSICION FARMACEUTICA QUE LOS CONTIENEN.Info
- Publication number
- AR073089A1 AR073089A1 ARP090103186A ARP090103186A AR073089A1 AR 073089 A1 AR073089 A1 AR 073089A1 AR P090103186 A ARP090103186 A AR P090103186A AR P090103186 A ARP090103186 A AR P090103186A AR 073089 A1 AR073089 A1 AR 073089A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- urea
- derivatives
- epipodofilotoxina
- aminoalquilaminoalquilamidas
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
La presente se refiere a derivadosde epipodofilotoxina 4-sustituidos con una cadena de (poli)aminoalquilaminoalquilamida o alquil-urea o alquil-sulfonamida opcionalmente sustituida, a un proceso para su preparacion y su uso como una medicina como un agente anticáncer. Reivindicacion 1: Un compuesto de la formula general (1) en donde: - R representa hidrogeno o alquilo C1-4, - A representa CO(CH2)n o CONH(CH2)n, donde n = 2, 3, 4 o 5, - R1 = H o alquilo C1-4, -R2= H, alquilo C1-4 o (CH2)m-NR3R4, donde m = 2, 3, 4 o 5, - R3 = H o alquilo C1-4, - R4 = H, alquilo C1-4 o (CH2)p-NR5R6, donde p = 2, 3, 4 o 5, - R5 = H o alquilo C1-4 y - R6 = H, alquilo C1-4 o (CH2)q-NH2, donde q = 2, 3, 4 o 5, o una de sus sales farmacéuticamente aceptables.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0855629A FR2935143B1 (fr) | 2008-08-19 | 2008-08-19 | Nouveaus derives (poly)aminoalkylaminoalkylamides, alkyl-urees, ou alkyl-sulfonamides d'epipodophyllotoxine, leur procede de preparation et leur application en therapeuthique comme agent cancereux |
Publications (1)
Publication Number | Publication Date |
---|---|
AR073089A1 true AR073089A1 (es) | 2010-10-13 |
Family
ID=40332868
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090103186A AR073089A1 (es) | 2008-08-19 | 2009-08-19 | DERIVADOS DE (POLI)AMINOALQUILAMINOALQUILAMIDAS, ALQUIL-UREA O ALQUILSULFONAMIDA DE EPIPODOFILOTOXINA, UN PROCESO PARA PREPARARLOS, SU APLICACIoN EN TERAPIA COMO AGENTES ANTICANCER Y COMPOSICION FARMACEUTICA QUE LOS CONTIENEN. |
Country Status (21)
Country | Link |
---|---|
US (2) | US8288567B2 (es) |
EP (1) | EP2326653B1 (es) |
JP (1) | JP5558470B2 (es) |
KR (1) | KR20110041513A (es) |
CN (1) | CN102131814B (es) |
AR (1) | AR073089A1 (es) |
AU (1) | AU2009284086B2 (es) |
BR (1) | BRPI0917237A2 (es) |
CA (1) | CA2733688A1 (es) |
FR (1) | FR2935143B1 (es) |
GE (1) | GEP20125689B (es) |
HK (1) | HK1156621A1 (es) |
IL (1) | IL211268A0 (es) |
MA (1) | MA32513B1 (es) |
MX (1) | MX2011001348A (es) |
NZ (1) | NZ590625A (es) |
RU (1) | RU2529676C2 (es) |
TW (1) | TW201011034A (es) |
UA (1) | UA106876C2 (es) |
WO (1) | WO2010020663A1 (es) |
ZA (1) | ZA201100650B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102603761B (zh) * | 2012-02-02 | 2013-12-25 | 华东师范大学 | 含有异羟肟酸结构的表鬼臼毒化合物及制备方法和用途 |
CN103664977B (zh) * | 2013-12-26 | 2018-01-30 | 天津工业大学 | 4‑斯德酮取代苯氨基表鬼臼毒素衍生物及其制备方法和应用 |
CN104945409A (zh) * | 2015-05-15 | 2015-09-30 | 东华大学 | 一种抗肿瘤活性化合物鬼臼毒素ppt的前药及其制备方法 |
CN110294764B (zh) * | 2019-07-15 | 2021-04-20 | 中国科学院兰州化学物理研究所 | 一种偶氮键连接的鬼臼毒素衍生物及其制备方法 |
CN113200994B (zh) * | 2021-04-27 | 2022-05-17 | 济宁市第一人民医院 | 鬼臼毒素羧酸酯类衍生物在制备抗肿瘤产品中的应用 |
CN113214281B (zh) * | 2021-05-19 | 2022-05-17 | 济宁市第一人民医院 | 一类苯磺酰胺苯丁酸鬼臼毒素酯类衍生物的合成及在抗癌药物中的应用 |
CN113801129A (zh) * | 2021-09-30 | 2021-12-17 | 大连民族大学 | 一种鬼臼毒素脂质衍生物、纳米载体及其制备方法和在肿瘤治疗中的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5300500A (en) * | 1989-02-23 | 1994-04-05 | The University Of North Carolina At Chapel Hill | 4 beta-amino podophyllotoxin analog compounds and methods |
TW221441B (es) * | 1991-01-25 | 1994-03-01 | Taiho Pharmaceutical Co Ltd | |
FR2742439B1 (fr) | 1995-12-14 | 1998-03-06 | Pf Medicament | Procede de preparation de la 4'-demethylepipodophyllotoxine a partir de la podophyllotoxine |
FR2810321B1 (fr) | 2000-06-20 | 2002-07-26 | Adir | Nouveaux derives de podophyllotoxine carbamate et thiocarbamate, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
WO2003082876A1 (en) | 2002-03-28 | 2003-10-09 | Council Of Scientific And Industrial Research | 4-beta-1''-`(2''-(substituted benzoyl)anilino! podophyllotoxin analogues useful as anticancer agents |
US7176236B2 (en) * | 2002-06-21 | 2007-02-13 | University Of North Carolina At Chapel Hill | Water-soluble etoposide analogs and methods of use thereof |
US6566393B1 (en) | 2002-06-21 | 2003-05-20 | The University Of North Carolina At Chapel Hill | Etoposide analogs and methods of use thereof |
EP1599485A2 (en) * | 2003-02-18 | 2005-11-30 | Ranbaxy Laboratories, Ltd. | Podophyllotoxin derivatives as antitumor agents |
FR2859208B1 (fr) * | 2003-09-02 | 2006-01-21 | Servier Lab | Nouveaux derives de 9-amino-podophyllotoxine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2869035B1 (fr) * | 2004-04-16 | 2006-07-14 | Pierre Fabre Medicament Sa | Derives (poly)aminoalkylaminoacetamide d'epipodophyllotoxine leur procede de preparation et leurs applications en therapeutique comme agent anticancereux |
FR2888849B1 (fr) | 2005-07-19 | 2007-10-05 | Pierre Fabre Medicament Sa | Procede de preparation de la 4b-amino-4'-demethyl-4-desoxypodophyllotoxine |
FR2921369B1 (fr) | 2007-09-25 | 2014-07-11 | Pf Medicament | Nouveau procede de preparation de derives (poly) aminoalkylaminoacetamide d'epipodophyllotoxine,utiles pour leurs applications en therapeutique comme agent anticancereux. |
-
2008
- 2008-08-19 FR FR0855629A patent/FR2935143B1/fr not_active Expired - Fee Related
-
2009
- 2009-08-18 TW TW098127718A patent/TW201011034A/zh unknown
- 2009-08-19 MX MX2011001348A patent/MX2011001348A/es active IP Right Grant
- 2009-08-19 KR KR1020117003236A patent/KR20110041513A/ko not_active Application Discontinuation
- 2009-08-19 WO PCT/EP2009/060739 patent/WO2010020663A1/en active Application Filing
- 2009-08-19 CA CA2733688A patent/CA2733688A1/en not_active Abandoned
- 2009-08-19 JP JP2011523421A patent/JP5558470B2/ja not_active Expired - Fee Related
- 2009-08-19 UA UAA201103228A patent/UA106876C2/uk unknown
- 2009-08-19 RU RU2011108485/04A patent/RU2529676C2/ru not_active IP Right Cessation
- 2009-08-19 CN CN200980132593.4A patent/CN102131814B/zh not_active Expired - Fee Related
- 2009-08-19 BR BRPI0917237A patent/BRPI0917237A2/pt not_active IP Right Cessation
- 2009-08-19 NZ NZ590625A patent/NZ590625A/en not_active IP Right Cessation
- 2009-08-19 US US12/737,645 patent/US8288567B2/en active Active
- 2009-08-19 GE GEAP200912109A patent/GEP20125689B/en unknown
- 2009-08-19 AR ARP090103186A patent/AR073089A1/es unknown
- 2009-08-19 EP EP09782006.2A patent/EP2326653B1/en active Active
- 2009-08-19 AU AU2009284086A patent/AU2009284086B2/en not_active Ceased
-
2011
- 2011-01-26 ZA ZA2011/00650A patent/ZA201100650B/en unknown
- 2011-01-28 MA MA33569A patent/MA32513B1/fr unknown
- 2011-02-17 IL IL211268A patent/IL211268A0/en unknown
- 2011-10-14 HK HK11110954.0A patent/HK1156621A1/xx not_active IP Right Cessation
-
2012
- 2012-07-17 US US13/551,119 patent/US8492567B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2326653B1 (en) | 2013-12-11 |
CN102131814A (zh) | 2011-07-20 |
ZA201100650B (en) | 2011-09-28 |
FR2935143A1 (fr) | 2010-02-26 |
UA106876C2 (uk) | 2014-10-27 |
RU2529676C2 (ru) | 2014-09-27 |
US20110172257A1 (en) | 2011-07-14 |
NZ590625A (en) | 2012-01-12 |
AU2009284086B2 (en) | 2014-02-06 |
AU2009284086A1 (en) | 2010-02-25 |
RU2011108485A (ru) | 2012-09-27 |
JP5558470B2 (ja) | 2014-07-23 |
US8492567B2 (en) | 2013-07-23 |
JP2012500249A (ja) | 2012-01-05 |
CN102131814B (zh) | 2014-03-26 |
HK1156621A1 (en) | 2012-06-15 |
IL211268A0 (en) | 2011-04-28 |
KR20110041513A (ko) | 2011-04-21 |
CA2733688A1 (en) | 2010-02-25 |
EP2326653A1 (en) | 2011-06-01 |
US8288567B2 (en) | 2012-10-16 |
BRPI0917237A2 (pt) | 2015-11-10 |
GEP20125689B (en) | 2012-11-12 |
FR2935143B1 (fr) | 2010-12-03 |
MX2011001348A (es) | 2011-03-29 |
MA32513B1 (fr) | 2011-07-03 |
WO2010020663A1 (en) | 2010-02-25 |
US20120283281A1 (en) | 2012-11-08 |
TW201011034A (en) | 2010-03-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CO2022002685A2 (es) | Nanopartículas lipídicas mejoradas para el suministro de ácidos nucleicos | |
AR073089A1 (es) | DERIVADOS DE (POLI)AMINOALQUILAMINOALQUILAMIDAS, ALQUIL-UREA O ALQUILSULFONAMIDA DE EPIPODOFILOTOXINA, UN PROCESO PARA PREPARARLOS, SU APLICACIoN EN TERAPIA COMO AGENTES ANTICANCER Y COMPOSICION FARMACEUTICA QUE LOS CONTIENEN. | |
DOP2011000264A (es) | Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia | |
SV2010003767A (es) | Compuestos pirazolicos 436 | |
NI201200184A (es) | Morfolinopirimidinas y su uso en terapia | |
CO2018004857A2 (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cáncer | |
UY35586A (es) | Derivados de la pirazolopirrolidina y su uso en el tratamiento de enfermedades | |
CR11641A (es) | Derivados heterociclicos de urea y metodos de uso de los mismos-211 | |
GT200600096A (es) | Composicion farmaceutica para el tratamiento del cancer | |
UY32158A (es) | Derivados heterociclicos y metodos de uso de los mismos | |
UY31481A1 (es) | Nuevos derivados de pirimidina, procesos de preparacion, composiciones farmacéuticas conteniéndolos y aplicaciones | |
UY33500A (es) | Derivados de acil sulfonamida y sus sales farmacéuticamente aceptables para uso en medicina | |
UY31272A1 (es) | Nuevos derivados de ácido azabifenilaminobenzoico | |
SV2010003713A (es) | Pirimidin-5-carboxamidas sustituidas 281 | |
UY33075A (es) | Derivados de ciclohexano y usos de los mismos | |
UY29234A1 (es) | Derivados de adamantano, composiciones farmacéuticas que los contienen, procedimientos de preparación de ambos y aplicaciones. | |
UY32315A (es) | Compuestos de piperidina y usos de los mismo-596 | |
CO6491060A2 (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
UY31141A1 (es) | Compuestos de piperidina y sus usos | |
UY30544A1 (es) | Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones | |
CR11825A (es) | Derivados de urea heterociclicos para el tratamiento de infecciones bacterianas | |
UY32674A (es) | Derivados heterociclicos de la urea y sus metodos de empleo | |
UY33348A (es) | Compuestos de furopiridina y usos de los mismos | |
UY31839A (es) | Compuestos | |
UY32316A (es) | Derivados de piperidina utiles en el tratamiento de infecciones bacterianas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |